We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.3B
AUM Growth
+$2.76B
(+22%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
12.55%
Top 10 Holdings %
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$335M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$122M |
| 3 |
JPMorgan Chase
JPM
|
+$113M |
| 4 |
Cheniere Energy
CQP
|
+$111M |
| 5 |
ENBL
ENABLE MIDSTREAM PARTNERS, LP
ENBL
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DM
Dominion Energy Midstream Ptr LP
DM
|
+$55.1M |
| 2 |
Navient
NAVI
|
+$47.5M |
| 3 |
Macy's
M
|
+$17.7M |
| 4 |
Occidental Petroleum
OXY
|
+$17M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 54.25% |
| 2 | Financials | 6.56% |
| 3 | Healthcare | 3.56% |
| 4 | Consumer Discretionary | 2.58% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
United Rentals
URI
$71.1B
| $1.18M | 0.01% |
8,014
+764
| +11% | +$125K |
|
302
Assembly Biosciences
ASMB
$506M
| $1.17M | 0.01% |
+2,485
| New | +$1.31M |
|
303
Old Republic International
ORI
$10.3B
| $1.17M | 0.01% |
58,510
-507
| -0.9% | -$10.6K |
|
304
Align Technology
ALGN
$12B
| $1.16M | 0.01% |
3,396
+1,161
| +52% | +$346K |
|
305
Antero Midstream
AM
$10.8B
| $1.16M | 0.01% |
61,222
-5,428
| -8% | -$96.4K |
|
|
FITB
306
Fifth Third Bancorp
FITB
$52B
| $1.15M | 0.01% |
40,160
-561
| -1% | -$17.8K |
|
|
CBAY
307
DELISTED
Cymabay Therapeutics
CBAY
| $1.15M | 0.01% |
+85,287
| New | +$1.07M |
|
|
ABMD
308
DELISTED
Abiomed Inc
ABMD
| $1.15M | 0.01% |
2,798
+2
| +0.1% | +$725 |
|
309
Fossil Group
FOSL
$239M
| $1.14M | 0.01% |
+42,541
| New | +$872K |
|
|
CMA
310
DELISTED
Comerica
CMA
| $1.14M | 0.01% |
12,512
+373
| +3% | +$35.7K |
|
311
Winnebago Industries
WGO
$870M
| $1.13M | 0.01% |
27,845
+4,172
| +18% | +$159K |
|
312
NVR
NVR
$17.2B
| $1.13M | 0.01% |
380
| – | – |
|
313
Matsons
MATX
$6.37B
| $1.13M | 0.01% |
+29,401
| New | +$975K |
|
314
Rocket Pharmaceuticals
RCKT
$348M
| $1.12M | 0.01% |
+57,177
| New | +$1.08M |
|
315
UroGen Pharma
URGN
$2B
| $1.12M | 0.01% |
22,451
+2,045
| +10% | +$119K |
|
316
Genworth Financial
GNW
$3.8B
| $1.1M | 0.01% |
245,502
+28,742
| +13% | +$99.1K |
|
317
Hartford Financial Services
HIG
$38.5B
| $1.1M | 0.01% |
21,549
+177
| +0.8% | +$9.27K |
|
318
Phillips 66
PSX
$82.9B
| $1.1M | 0.01% |
9,792
-231
| -2% | -$26K |
|
319
Humana
HUM
$46.7B
| $1.09M | 0.01% |
3,675
+334
| +10% | +$97.8K |
|
320
Enova International
ENVA
$5.91B
| $1.09M | 0.01% |
29,755
+2,315
| +8% | +$70.4K |
|
321
The RMR Group
RMR
$342M
| $1.08M | 0.01% |
13,830
+6,962
| +101% | +$536K |
|
322
Walker & Dunlop
WD
$1.65B
| $1.07M | 0.01% |
19,264
+10,035
| +109% | +$578K |
|
323
Entergy
ETR
$54.1B
| $1.07M | 0.01% |
26,500
+2,568
| +11% | +$102K |
|
324
Abbott
ABT
$180B
| $1.07M | 0.01% |
17,514
+1,611
| +10% | +$97.7K |
|
325
InterDigital
IDCC
$6.68B
| $1.06M | 0.01% |
+13,055
| New | +$1.04M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.
By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.
- ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
- ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
- ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
- ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
- ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
- ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
- ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.
Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.